Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, M. B.
Right arrow Articles by Kohn, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, M. B.
Right arrow Articles by Kohn, E. C.
Clinical Cancer Research Vol. 9, 44-51, January 2003
© 2003 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

The Granulin-Epithelin Precursor/PC-Cell-derived Growth Factor Is a Growth Factor for Epithelial Ovarian Cancer

Monica Brown Jones, Chad M. Michener, James O. Blanchette, Vladimir A. Kuznetsov, Mark Raffeld, Ginette Serrero, Michael R. Emmert-Buck, Emanuel F. Petricoin, David B. Krizman, Lance A. Liotta and Elise C. Kohn1

Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892-1500 [M. B. J., C. M. M., J. O. B., M. R., M. R. E-B., D. B. K., L. A. L., E. C. K.]; Laboratory of Integrative and Medical Biophysics, National Institute of Child Health and Human Development, Bethesda, Maryland [V. A. K.,]; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland [G. S.]; Marlene and Stewart Greenebaum Cancer Center of the University of Maryland, Baltimore, Maryland [G. S.]; and Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland [E. F. P.]

Purpose: The role of growth factors in ovarian cancer development and progression is complex and multifactorial. We hypothesized that new growth factors may be identified through the molecular analysis of ovarian tumors as they exist in their native environment.

Experimental Design: RNA extracted from microdissected serous low malignant potential (LMP) and invasive ovarian tumors was used to construct cDNA libraries. A total of 7300 transcripts were randomly chosen for sequencing, and those transcripts were statistically evaluated. Reverse transcription-PCR and immunohistochemistry were used to validate the findings in tumor tissue samples. Ovarian cancer cell lines were used to test gene effects on monolayer growth, proliferative capacity, and density-independent growth.

Results: Analysis of the pooled library transcripts revealed 26 genes differentially expressed between LMP and invasive ovarian cancers. The granulin-epithelin precursor [GEP/PC-cell derived growth factor (PCDGF)] was expressed only in the invasive ovarian cancer libraries (P < 0.028) and was absent in the LMP libraries (0 of 2872 clones). All of the invasive tumor epithelia, 20% of the LMP tumor epithelia, and all of the stroma from both subsets expressed GEP by reverse transcription-PCR. Immunohistochemical staining for GEP was diffuse and cytosolic in invasive ovarian cancer tumor cells compared with occasional, punctate, and apical staining in LMP tumor epithelia. Antisense transfection of GEP into ovarian cancer cell lines resulted in down-regulation of GEP production, reduction in cell growth (P < 0.002), decrease in the S-phase fraction (P < 0.04), and loss of density-independent growth potential (P < 0.01).

Conclusion: cDNA library preparation from microdissected tumor epithelium provided a selective advantage for the identification of growth factors for epithelial ovarian cancer. Differential granulin expression in tumor samples and the antiproliferative effects of its antisense down-regulation suggest that GEP may be a new autocrine growth factor and molecular target for epithelial ovarian cancer.




This article has been cited by other articles:


Home page
Protein Sci.Home page
D. Tolkatchev, S. Malik, A. Vinogradova, P. Wang, Z. Chen, P. Xu, H. P.J. Bennett, A. Bateman, and F. Ni
Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities
Protein Sci., April 1, 2008; 17(4): 711 - 724.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. A. Simpkins, N. M. Devoogdt, N. Rasool, N. E. Tchabo, E. U. Alejandro, M. M.R.N. Kamrava, and E. C. Kohn
The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells
Carcinogenesis, March 1, 2008; 29(3): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. H. P. Ong, Z. He, L. Kriazhev, X. Shan, R. G. E. Palfree, and A. Bateman
Regulation of progranulin expression in myeloid cells
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1602 - R1612.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. B. Jones, A. P. Houwink, B. K. Freeman, T. M. Greenwood, J. M. Lafky, W. L. Lingle, A. Berchuck, G. L. Maxwell, K. C. Podratz, and N. J. Maihle
The Granulin-Epithelin Precursor Is a Steroid-Regulated Growth Factor in Endometrical Cancer
Reproductive Sciences, May 1, 2006; 13(4): 304 - 311.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
P. C. Hanington, D. R. Barreda, and M. Belosevic
A Novel Hematopoietic Granulin Induces Proliferation of Goldfish (Carassius auratus L.) Macrophages
J. Biol. Chem., April 14, 2006; 281(15): 9963 - 9970.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Matsumura, M. Mandai, M. Miyanishi, K. Fukuhara, T. Baba, T. Higuchi, M. Kariya, K. Takakura, and S. Fujii
Oncogenic Property of Acrogranin in Human Uterine Leiomyosarcoma: Direct Evidence of Genetic Contribution in In vivo Tumorigenesis
Clin. Cancer Res., March 1, 2006; 12(5): 1402 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
E. M. Posadas, F. Simpkins, L. A. Liotta, C. MacDonald, and E. C. Kohn
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
Ann. Onc., January 1, 2005; 16(1): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. T. Cheung, S. Y. Wong, K. L. Leung, X. Chen, S. So, I. O. Ng, and S. T. Fan
Granulin-Epithelin Precursor Overexpression Promotes Growth and Invasion of Hepatocellular Carcinoma
Clin. Cancer Res., November 15, 2004; 10(22): 7629 - 7636.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Chevillard, N. Ugolin, P. Vielh, K. Ory, C. Levalois, D. Elliott, G. L. Clayman, and A. K. El-Naggar
Gene Expression Profiling of Differentiated Thyroid Neoplasms: Diagnostic and Clinical Implications
Clin. Cancer Res., October 1, 2004; 10(19): 6586 - 6597.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Tangkeangsirisin and G. Serrero
PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells
Carcinogenesis, September 1, 2004; 25(9): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Tangkeangsirisin, J. Hayashi, and G. Serrero
PC Cell-Derived Growth Factor Mediates Tamoxifen Resistance and Promotes Tumor Growth of Human Breast Cancer Cells
Cancer Res., March 1, 2004; 64(5): 1737 - 1743.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.-X. Pan, M. S. Kinch, P. A. Kiener, S. Langermann, G. Serrero, L. Sun, J. Corvera, C. J. Sweeney, L. Li, S. Zhang, et al.
PC Cell-Derived Growth Factor Expression in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma
Clin. Cancer Res., February 15, 2004; 10(4): 1333 - 1337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.